Mdm2
信号通路图
研究领域
抑制剂选择性比较
特异性亚型抑制剂
Mdm2产品
| 目录号 | 产品描述 | 文献引用 | 实验数据 |
|---|---|---|---|
| S2678 |
NSC 207895NSC 207895抑制MDMX，IC50为2.5 μM，促进p53稳定/激活和DNA损伤，也调节MDM2（E3连接酶）。 |
Median overall survival of mice (n = 5 mice in vehicle and PYR-41; n = 4 mice in NSC group) inoculated with IOWA-1T xenografts were increased to 43 ± 0.5 and 39 ± 2 days with PYR-41 (PYR) and NSC-207895 (NSC), respectively, compared with a vehicle-treated control group 33 ± 1 days (*p < 0.05).
|
|
| S8059 |
Nutlin-3aNutlin-3a 是Nutlin-3的活性对映体，抑制p53/MDM2相互作用，无细胞试验中IC50为90 nM。Nutlin-3a 可诱导p53依赖的自噬和细胞凋亡。 |
Nutlin-3a preserved p53 expression without influencing high glucose (HG)-induced podocyte impairment. A-D: cultured podocytes were pre-treated by nutlin-3a for 2 hrs before subjected to HG treatment. Western blotting gel documents (A) and summarized data (B) showing the expression of p53 and MDM2 in podocytes under HG exposure for 24 hrs. n = 4. Western blotting gel documents (C) and summarized data (D) showing the expression of Desmin in podocytes under HG exposure for 24 hrs. n = 3. *P < 0.05 vs. Ctrl, #P < 0.05 vs. Vehl + HG. Ctrl: control; Vehl: vehicle; nutlin-3a: nutlin-3a treatment. |
|
| S7030 |
RG-7112RG7112 (RO5045337)是一种口服具有活性的选择性p53-MDM2抑制剂，HTRF IC50为18 nM。 |
||
| S7875 |
NVP-CGM097NVP-CGM097是一种高效的、选择性的MDM2抑制剂， Ki值为1.3 nM。它与MDM2蛋白的p53结合位点结合，破坏其蛋白间相互作用，导致p53通路的激活。 |
(C) SACi2 effects are dependent on MT-kinetochore attachments. The graph shows percentage of cells undergoing forced mitotic exit by SACi2 or DMSO in various pretreatment conditions (mean ± SEM, three independent assays). Nocodazole (Noc) was used at 70 nM and 3 μM, vinblastine (Vbl) at 1 μM, taxol (Tx) at 600 nM and monastrol (Mon) at 100 μM concentrations and were added 8 h before addition of DMSO or SACi2. MG132 (20 μM) was added 1 h before nocodazole.
|
|
| S8403 |
MX69MX69是MDM2/XIAP抑制剂，其结合MDM2 RING 蛋白的Kd值为2.34 μM。用于治疗癌症。 |
||
| S8606 |
HDM201 (Siremadlin)HDM201是一种新型的、高效的、选择性的p53-Mdm2 interaction抑制剂，对Mdm2的亲合常数在皮摩尔范围内，对Mdm2的选择性是对Mdm4的1000倍以上。 |
||
| S7205 |
Idasanutlin (RG-7388)Idasanutlin (RG-7388)是一种有效的选择性p53-MDM2抑制剂,其IC50为6 nM。其体外结合力和在细胞中的效力、选择性都有极大的改善。 |
||
| S2341 |
(-)-Parthenolide(-)-Parthenolide, Nuclear Factor-κB抑制剂，可特异性地耗尽HDAC1蛋白，而不影响其他I/II类 HDACs。促进MDM2的泛素化并激活p53的细胞功能。 |
-Parthenolide-S234101W0220161110.gif)
-Parthenolide-S234101W0220161110.gif)
G. To evaluate effects of IKBKE/TBK1 inhibition on NF-κB signaling in Ewing, TC32 cells were incubated with CYT387 for six hours prior to stimulation with TNF-α (30 ng/mL). IκBα degradation was measured by harvesting TC32 cells thirty minutes after stimulation with TNF-α. TNF-α stimulation resulted in degradation of IκBα, and this effect was attenuated with CYT387 treatment. Parthenolide, an inhibitor of IκBα phosphorylation was used as a positive control. Similar effects of CYT387 activity were seen in HEK-293T cells which also express IKBKΕ. Nuclear extracts were prepared from TC32 cells harvested following forty-five minutes of TNF-α stimulation. Treatment with CYT387 resulted in decreased nuclear localization of NF-κB family proteins RelA/p65 and c-Rel. There was a modest impairment of p50 nuclear localization as compared to parthenolide and DMSO controls and no change in p52 nuclear localization. RelB (not shown) is not expressed in TC32 cells |
|
| S1061 |
Nutlin-3Nutlin-3是一种有效的，选择性Mdm2(它自身和p53的环指依赖性泛素蛋白连接酶)拮抗剂，无细胞试验中IC50为90 nM；可稳定p53缺陷细胞中的p73。 |
Ubiquitination of p53 in vivo by BIRC6 in the presence of Nutlin-3. Cells were treated with Nutlin-3 (20 uM, 24 h) before harvest. Cell lysates were immunoprecipitated with anti-p53 antibody and immunoblotted by anti-ubiquitin antibody.
|
|
| S8065 |
Nutlin-3bNutlin-3b是一种p53/MDM2拮抗剂或抑制剂，IC50值为13.6μM，是Nutlin-3的（+）-对映体，比(-)-对映体Nutlin-3a作用效果低150倍。 |
Dissociative effect of Nutlin-3a, Nutlin-3b, and RO-5963 on the preformed p53·MDM2 complex. Representative electrophoresis polyacrylamide gels in nondenaturing conditions for the analysis of the dissociation power of the inhibitors tested. (A) The reaction mixture containing 25 M p53·MDM2 complex, treated in the absence (lane 3) or in the presence (lanes 4-14) of 0.040, 0.060, 0.080, 0.12,
0.33, 0.67, 1.33, 3.33, 6.67, 33.33, and 333.33 μM Nutlin-3a, respectively, were run on a 12% nondenaturing polyacrylamide gel. Thirty micromolar MDM2 and p53 was run alone in lanes 1 and 2, respectively. (B) As in (A), but using Nutlin-3b, at concentration of (lanes 4-14) of 1.33, 6.67, 13.33, 20.00, 66.67, 133.33, 266.67, 333.33, 400.00, 833.33, and 1666.67 μM. p53 and MDM2 (25 μM both) were run alone in lanes 1 and 2, respectively. (C) As in (A), but using RO-5963, at concentration of 0.10, 0.21, 0.42, 0.83, 1.67, 3.33, 8.33, 16.67, 33.33, 166.67, and 333.33 μM (lanes 4-14), respectively. (D) The percentage of the residual p53·MDM2 complex was reported in a semilogarithmic plot, at the corresponding concentration of Nutlin-3a (empty circles), RO-5963 (triangles), and Nutlin-3b (filled circles), respectively. (E) The percentage of MDM2 dissociated from the complex was reported as a function of the inhibitor concentration. Curve fitting was done using the hyperbolic function. Symbols as in (D).
|
|
| S7649 |
MI-773 (SAR405838)MI-773 (SAR405838) 是一种口服生物有效的MDM2拮抗剂，Ki为0.88 nM。Phase 1。 |
A panel of four NB cell lines were seeded in six-well plates with indicated concentrations of SAR405838 and agar, and grown for 2 to 3 weeks. Cells were stained with crystal violet for 4 hours. Colonies were counted and colony numbers were represented as % vehicle ± S.D. with P < 0.05 (*), P < 0.01 (**) or P < 0.001 (***) (Student's t-test, two-tailed) as indicated.
|
|
| S7489 |
YH239-EEYH239-EE,YH239乙酯,是一种强效的 p53-MDM2 拮抗剂和细胞凋亡诱导剂。 |
| 目录号 | 产品描述 | 文献引用 | 实验数据 |
|---|---|---|---|
| S2678 |
NSC 207895NSC 207895抑制MDMX，IC50为2.5 μM，促进p53稳定/激活和DNA损伤，也调节MDM2（E3连接酶）。 |
Median overall survival of mice (n = 5 mice in vehicle and PYR-41; n = 4 mice in NSC group) inoculated with IOWA-1T xenografts were increased to 43 ± 0.5 and 39 ± 2 days with PYR-41 (PYR) and NSC-207895 (NSC), respectively, compared with a vehicle-treated control group 33 ± 1 days (*p < 0.05).
|
|
| S8059 |
Nutlin-3aNutlin-3a 是Nutlin-3的活性对映体，抑制p53/MDM2相互作用，无细胞试验中IC50为90 nM。Nutlin-3a 可诱导p53依赖的自噬和细胞凋亡。 |
Nutlin-3a preserved p53 expression without influencing high glucose (HG)-induced podocyte impairment. A-D: cultured podocytes were pre-treated by nutlin-3a for 2 hrs before subjected to HG treatment. Western blotting gel documents (A) and summarized data (B) showing the expression of p53 and MDM2 in podocytes under HG exposure for 24 hrs. n = 4. Western blotting gel documents (C) and summarized data (D) showing the expression of Desmin in podocytes under HG exposure for 24 hrs. n = 3. *P < 0.05 vs. Ctrl, #P < 0.05 vs. Vehl + HG. Ctrl: control; Vehl: vehicle; nutlin-3a: nutlin-3a treatment. |
|
| S7030 |
RG-7112RG7112 (RO5045337)是一种口服具有活性的选择性p53-MDM2抑制剂，HTRF IC50为18 nM。 |
||
| S7875 |
NVP-CGM097NVP-CGM097是一种高效的、选择性的MDM2抑制剂， Ki值为1.3 nM。它与MDM2蛋白的p53结合位点结合，破坏其蛋白间相互作用，导致p53通路的激活。 |
(C) SACi2 effects are dependent on MT-kinetochore attachments. The graph shows percentage of cells undergoing forced mitotic exit by SACi2 or DMSO in various pretreatment conditions (mean ± SEM, three independent assays). Nocodazole (Noc) was used at 70 nM and 3 μM, vinblastine (Vbl) at 1 μM, taxol (Tx) at 600 nM and monastrol (Mon) at 100 μM concentrations and were added 8 h before addition of DMSO or SACi2. MG132 (20 μM) was added 1 h before nocodazole.
|
|
| S8403 |
MX69MX69是MDM2/XIAP抑制剂，其结合MDM2 RING 蛋白的Kd值为2.34 μM。用于治疗癌症。 |
||
| S8606 |
HDM201 (Siremadlin)HDM201是一种新型的、高效的、选择性的p53-Mdm2 interaction抑制剂，对Mdm2的亲合常数在皮摩尔范围内，对Mdm2的选择性是对Mdm4的1000倍以上。 |
||
| S7205 |
Idasanutlin (RG-7388)Idasanutlin (RG-7388)是一种有效的选择性p53-MDM2抑制剂,其IC50为6 nM。其体外结合力和在细胞中的效力、选择性都有极大的改善。 |
||
| S2341 |
(-)-Parthenolide(-)-Parthenolide, Nuclear Factor-κB抑制剂，可特异性地耗尽HDAC1蛋白，而不影响其他I/II类 HDACs。促进MDM2的泛素化并激活p53的细胞功能。 |
G. To evaluate effects of IKBKE/TBK1 inhibition on NF-κB signaling in Ewing, TC32 cells were incubated with CYT387 for six hours prior to stimulation with TNF-α (30 ng/mL). IκBα degradation was measured by harvesting TC32 cells thirty minutes after stimulation with TNF-α. TNF-α stimulation resulted in degradation of IκBα, and this effect was attenuated with CYT387 treatment. Parthenolide, an inhibitor of IκBα phosphorylation was used as a positive control. Similar effects of CYT387 activity were seen in HEK-293T cells which also express IKBKΕ. Nuclear extracts were prepared from TC32 cells harvested following forty-five minutes of TNF-α stimulation. Treatment with CYT387 resulted in decreased nuclear localization of NF-κB family proteins RelA/p65 and c-Rel. There was a modest impairment of p50 nuclear localization as compared to parthenolide and DMSO controls and no change in p52 nuclear localization. RelB (not shown) is not expressed in TC32 cells |
| 目录号 | 产品描述 | 文献引用 | 实验数据 |
|---|---|---|---|
| S1061 |
Nutlin-3Nutlin-3是一种有效的，选择性Mdm2(它自身和p53的环指依赖性泛素蛋白连接酶)拮抗剂，无细胞试验中IC50为90 nM；可稳定p53缺陷细胞中的p73。 |
Ubiquitination of p53 in vivo by BIRC6 in the presence of Nutlin-3. Cells were treated with Nutlin-3 (20 uM, 24 h) before harvest. Cell lysates were immunoprecipitated with anti-p53 antibody and immunoblotted by anti-ubiquitin antibody.
|
|
| S8065 |
Nutlin-3bNutlin-3b是一种p53/MDM2拮抗剂或抑制剂，IC50值为13.6μM，是Nutlin-3的（+）-对映体，比(-)-对映体Nutlin-3a作用效果低150倍。 |
Dissociative effect of Nutlin-3a, Nutlin-3b, and RO-5963 on the preformed p53·MDM2 complex. Representative electrophoresis polyacrylamide gels in nondenaturing conditions for the analysis of the dissociation power of the inhibitors tested. (A) The reaction mixture containing 25 M p53·MDM2 complex, treated in the absence (lane 3) or in the presence (lanes 4-14) of 0.040, 0.060, 0.080, 0.12,
0.33, 0.67, 1.33, 3.33, 6.67, 33.33, and 333.33 μM Nutlin-3a, respectively, were run on a 12% nondenaturing polyacrylamide gel. Thirty micromolar MDM2 and p53 was run alone in lanes 1 and 2, respectively. (B) As in (A), but using Nutlin-3b, at concentration of (lanes 4-14) of 1.33, 6.67, 13.33, 20.00, 66.67, 133.33, 266.67, 333.33, 400.00, 833.33, and 1666.67 μM. p53 and MDM2 (25 μM both) were run alone in lanes 1 and 2, respectively. (C) As in (A), but using RO-5963, at concentration of 0.10, 0.21, 0.42, 0.83, 1.67, 3.33, 8.33, 16.67, 33.33, 166.67, and 333.33 μM (lanes 4-14), respectively. (D) The percentage of the residual p53·MDM2 complex was reported in a semilogarithmic plot, at the corresponding concentration of Nutlin-3a (empty circles), RO-5963 (triangles), and Nutlin-3b (filled circles), respectively. (E) The percentage of MDM2 dissociated from the complex was reported as a function of the inhibitor concentration. Curve fitting was done using the hyperbolic function. Symbols as in (D).
|
|
| S7649 |
MI-773 (SAR405838)MI-773 (SAR405838) 是一种口服生物有效的MDM2拮抗剂，Ki为0.88 nM。Phase 1。 |
A panel of four NB cell lines were seeded in six-well plates with indicated concentrations of SAR405838 and agar, and grown for 2 to 3 weeks. Cells were stained with crystal violet for 4 hours. Colonies were counted and colony numbers were represented as % vehicle ± S.D. with P < 0.05 (*), P < 0.01 (**) or P < 0.001 (***) (Student's t-test, two-tailed) as indicated.
|
|
| S7489 |
YH239-EEYH239-EE,YH239乙酯,是一种强效的 p53-MDM2 拮抗剂和细胞凋亡诱导剂。 |
沪公网安备 31011502012800号